Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
Median time to correct treatment significantly shorter for mpMRI-staged versus transurethral resection of bladder cancer-staged care
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa
PFAS in Drinking Water Linked to Increased Cancer Incidence
Increased cancer incidence seen in digestive, endocrine, oral cavity/pharynx, and respiratory systems between 2016 and 2021
Cancer Mortality Continued to Decline Through 2022
However, increase seen in incidence in women, especially for middle-aged and younger women
PSMA-PET Provides Additional Risk Stratification in High-Risk Prostate Cancer
M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer
Tubal Sterilization, Vasectomy Visits on the Rise After Dobbs Decision
Tubal sterilization and vasectomy visits increased among participants aged 19 to 26 years after May 2022 leaked opinion
DoxyPEP Tied to Decreases in Sexually Transmitted Infections
Substantial declines seen in chlamydia and syphilis incidence after initiation
Clinical Manifestations Differ Between Interstitial Cystitis, Bladder Pain Syndrome
Those with interstitial cystitis show worse symptom severity, bladder function
Ultrasound, 3D Printing Aid Sacral Neuromodulation for Neurogenic Bladder
Fewer punctures and shorter surgical time reported for sacral neuromodulation with 3D printing and ultrasound localization
Patient-Centered Pathology Reports Improve Prostate Cancer Understanding
Benefits include better discrimination between risk levels
